Drug Repurposing: New Treatments for Zika Virus Infection?
2016
To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
9
References
48
Citations
NaN
KQI